Leishmania chagasi, as it cycles between an insect and mammalian host, must alter expression of virulence factors to survive within these diverse environments. The scientific hypothesis underlying this research proposal is that regulation of leishmania genes is controlled by stage-specific signals that either upregulate or down-regulate proteins essential for adaptation to the host environment. To address this hypothesis, we plan to study the molecular mechanism by which L. chagasi regulates the expression of the MSP gene family. The overall purpose of this Mentored Clinical Scientist Award application is to provide the applicant with the necessary didactic training program and scientific environment to embark on his independent research career in the field of molecular parasitology. The abundance of the major surface protease MSP (also called GP63) increases during growth of L. chagasi from logarithmic to stationary phase in vitro, in parallel with a developmental increase in parasite virulence. Coincident changes occur in expression ofMSP RNA. Three distinct classes of MSP genes (MSPL, MSPS, MSPC) encode MSP. We previously reported that the abundance ofMSPL RNAs is regulated by shortening of its rnRNA half-life (T1/2) during growth to stationary phase. Furthermore, culture with inhibitors of protein synthesis such as cycloheximide prolongs the MSPL RNA T1/2. Parasites transfected with reporter gene constructs showed that sequences within the MSPL 3'UTR are responsible for the cycloheximide-induced increase in MSPL RNA T1/2, possibly by interacting with a labile protein factor that destabilizes MSPL mRNA.
The specific aims of this work are:
Aim 1. Identify the cis-acting sequences contained within the 3'UTR of MSPL that are responsible for the cycloheximide dependant increase in mRNA abundance.
Aim 2. Confirm that putative cis-acting regulatory elements are responsible for in vivo mRNA regulation.
Aim 3. Isolate genes encoding protein(s) that specifically bind to the cis-acting elements identified in Aim 1. This project should provide the background to launch an independent research program focusing on cis-acting factors and trans-acting elements influencing expression of leishmania genes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
7K08AI055804-04
Application #
7193887
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Rogers, Martin J
Project Start
2003-08-01
Project End
2006-05-31
Budget Start
2005-09-16
Budget End
2006-05-31
Support Year
4
Fiscal Year
2005
Total Cost
$117,864
Indirect Cost
Name
University of Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637